A bipartisan group of senators is probing the health data sharing practices of telehealth companies Cerebral, Monument, and Workit Health.February 7, 2023Check out STAT+Sponsored By J. Scott Applewhite/AP Senators probe telehealth companies for tracking and monetizing sensitive health data A bipartisan group of senators is probing the health data sharing practices of telehealth companies Cerebral, Monument, and Workit Health. By John Wilkerson New mouse study shows genes aren't only way to pass obesity to next generation The growing field of epigenetics gets another paper challenging centuries of evolutionary convention about inheritance. By Jonathan Wosen STAT+ | Angry at Vertex pricing of cystic fibrosis drugs, families in four countries seek to override patents Families and activists are petitioning four governments to make generic versions of expensive Vertex cystic fibrosis drugs accessible. By Ed Silverman Adobe Mm-hm, uh-huh: AI-powered medical scribes still can't understand our conversations Microsoft and others are working on automated transcription systems for medical appointments. But "mm-hms" and mumbles are tripping them up. By Brittany Trang STAT+ | Pharma loses a court battle in its bid to block states from importing drugs from Canada A federal judge has tossed a lawsuit that sought to prevent state governments from importing medicines from Canada. By Ed Silverman STAT+ | Chinese DNA giant's U.S. affiliate looks to rival Illumina, touting $100 genome and high-power sequencers The firm plans to launch sequencers it says can decode DNA in larger amounts — and at lower costs — than any instrument on the market. By Jonathan Wosen Adobe Opinion: The tyranny of the inbox: What it's like to be a PCP with OCD For a physician with OCD, the perpetual flood of messages from patients, test results, and notifications from the EMR can be overwhelming. By Russell Johnson STAT+ | Gene therapy pioneer Kathy High leaves AskBio In an interview, Kathy High didn't comment directly on her reasons for leaving but praised the biotech and its technology. By Jason Mast More around STATCheck out more exclusive coverage with a STAT+ subscriptionRead premium in-depth biotech, pharma, policy, and life science coverage and analysis with all of our STAT+ articles.Enjoying Daily Recap? Tell us about your experienceContinue reading the latest health & science news with the STAT appDownload on the App Store or get it on Google Play STAT, 1 Exchange Place, Boston, MA©2023, All Rights Reserved.I no longer wish to receive STAT emailsUpdate Newsletter Preferences • Contact Us • Advertise with Us • View in Browser
No comments